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ABSTRACT
Objective To evaluate the association between chromosomal
abnormalities and fetal cerebellar size.
Design A retrospective cross-sectional study.
Methods Ultrasound measurements of transcerebellar dia-
meter, head and upper-abdominal circumference from 88 fetuses
with chromosomal abnormalities were analyzed. Abnormal-
ities included trisomy 21 (n = 23), trisomy 18 (n = 17), ‘other
numerical chromosomal abnormalities’ (n = 9), sex chromo-
somal abnormalities (n = 9), mosaicism (n = 12), balanced
translocations (n = 9) and unbalanced translocations (n = 9).
Multiple regression analysis was performed to compare trans-
cerebellar diameters between the reference group and each
of the subsets of chromosomal abnormalities and between
trisomies 18 and 21. Also, in the latter two subsets, comparison
of the transcerebellar diameter before and after 25 weeks of
gestation was carried out.
Results Fetal transcerebellar diameter was reduced in relation
to gestational age but was normal when control was made for
fetal size in all chromosomal subsets, except for balanced
translocations. The transcerebellar diameter in trisomy 18
was significantly smaller than that in trisomy 21. No difference
in cerebellar size was found when comparing the gestational age
period before and after 25 weeks in each of these two subsets.
Conclusions A reduction in fetal transcerebellar diameter
was demonstrated in all chromosomal abnormalities with
imbalance of genetic material. Cerebellar hypoplasia was
more severe in trisomy 18 than in trisomy 21. The degree of
reduction in fetal transcerebellar diameter in these subsets
seems to be independent of the time period during which the
transcerebellar diameter measurement was performed.
INTRODUCTION
Fetal cerebellar size can be measured by ultrasound at as early
as 11 weeks of gestation. Several studies have reported on fetal
cerebellar size in association with chromosomal abnormalities.
These were mostly diagnosed in early pregnancy, with em-
phasis on trisomies 18 and 211–4. The association between
trisomy 21 and fetal transcerebellar diameter is controversial
in that some reports suggest a reduction in size1 whereas other
reports do not2,3. When a difference in cerebellar size between
normal cases and cases with trisomy 21 was demonstrated, it
was too small to be clinically useful1. The effect of chromo-
somal abnormalities on intracerebral anatomy in general has
been studied mainly in neonates and infants by means of
neuropathology and brain imaging using either computed
tomography or magnetic resonance imaging5–10. Neonatal
cerebellar hypoplasia has been established for a range of
chromosomal abnormalities including trisomies 18 and 215,9,10.
In vitro experiments describe longer cell cycle times in
embryonic cells with chromosomal abnormalities11. It
has been postulated that trisomic cells can participate in
normal embryonic and postnatal development except for
certain critical stages when rapid cell division is required,
as is the case during early development of the brain12. There
are two major periods of cellular multiplication in the human
brain: from 15–20 weeks of gestation and from 25 weeks
until 2–4 years of age13.
The aim of the present study was to test the hypothesis that:
(i) a chromosomal abnormality established during the second
half of pregnancy is associated with a reduction in cerebellar
size (ii) the diagnosis of cerebellar hypoplasia is dependent on
the time period during which the transcerebellar diameter
measurement is performed.
Fetal cerebellar size was evaluated retrospectively, accord-
ing to a cross-sectional study design in 88 second- and third-
trimester pregnancies representing a wide range of numerical
and structural chromosomal abnormalities. Fetal cerebellar
measurements were compared between the periods before
and after 25 weeks of gestation.
MATERIALS AND METHODS
We retrospectively analyzed fetal transverse cerebellar dia-
meter (TCD) measurements in 88 singleton pregnancies with
a fetal chromosomal abnormality. The group consisted of 23
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cases of trisomy 21; 17 cases of trisomy 18; nine cases of other
numerical chromosomal abnormalities (monosomy, n = 2;
triploidy, n = 4; trisomy 13, n = 3); nine cases of sex chromo-
somal abnormalities (47,XXX, n = 1; 47,XXY, n = 2; 45,X,
n = 6), 12 cases of mosaicism, nine cases of balanced trans-
locations and nine cases of unbalanced translocations.
Patients were referred between January 1990 and January
1998 from regional community hospitals for prenatal diagnosis
in our center because of ( i) maternal age ≥ 36 years; (ii) increased
risk for fetal chromosomal abnormalities based on a previously
affected infant; (iii) a suspected fetal abnormality in the current
pregnancy.
Women were selected under the following conditions:
(i) reliable menstrual dates; (ii) ultrasound confirmation of men-
strual dates by means of crown–rump length (CRL) or biparietal
diameter (BPD) measurement; (iii) available TCD measure-
ment. In each case transabdominal chorionic villus sampling
or amniocentesis was performed for fetal karyotyping. All
women gave informed consent to participate in the study and
the approval of the hospital ethics committee was obtained.
Mean maternal age was 33 years (range, 27–40 years). Mean
gestational age at the time of the ultrasound examination was
23 weeks (range, 17–34 weeks).
Ultrasound examinations were carried out using a Toshiba
SHH-140 A (Toshiba Corporation, Medical Systems Divisions,
Tokyo, Japan) or ATL HDI-3000 (ATL Ultrasound, Bothell,
WA, USA) with a 3.5 or 5.0-MHz transducer. Fetal biometry
included measurement of the BPD (in mm), head circum-
ference (HC in mm), TCD (in mm), abdominal circumference
(AC in mm) and femur length (FL in mm). The BPD and HC
were measured from a transverse cross section of the fetal
head at the level of the thalamus and cavum septi pellucidi.
By slightly rotating the transducer below the thalamic plane,
the posterior fossa became visible, imaging the characteristic
shape of the cerebellum. The TCD was measured in an outer-
to-outer fashion. The AC was obtained from a transverse
cross-section at the level of the junction of the umbilical vein
and left portal vein. The TCD, AC and HC data are presented.
Reference data for TCD relative to gestational age, HC and
AC were obtained from a previous study in our own center
based on 360 uncomplicated pregnancies between 17 and
34 weeks of gestation14.
Biometric data of each affected fetus were included in the
study only once.
Statistical analysis
In order to compare TCD values between the reference group
and each of the subsets of chromosomal abnormalities,
multiple linear regression analysis was performed for each of
these subsets. The assumption was made that there was no
difference in residual variance between a particular subset and
the reference group. This could be confirmed after visual inspec-
tion of scatter plots of the residuals, allowing the use of pooled
data in the regression analysis. After logarithmic transforma-
tion, the regression line of TCD relative to gestational age
in each subset was compared with the regression line in the
reference group. Student’s t-test was applied to test the signi-
ficance of the difference in slope and intercept between the
regression line in a particular subset and the reference group.
The same method was used to test differences between the
regression lines of transcerebellar diameter relative to gesta-
tional age in trisomies 18 and 21.
Based on the 5th centile of the reference chart for TCD
relative to gestational age, the distribution of TCD values
before and after 25 weeks of gestation in trisomies 18
and 21 was compared using Fisher’s exact test in 2 × 2 cross
tables.
P-values below 0.05 were considered to denote statistical
significance.
RESULTS
Figures 1 and 2 provide individual biometric data plots for all
seven subsets.
The TCD values in all but one subset of chromosomal
abnormalities were statistically significantly lower (P < 0.05)
than the values from the normal population. In trisomy 21
and other numerical chromosomal abnormalities the slope as
well as the intercept of the regression line was significantly
lower than in the reference group; in trisomy 18 the slope of
the regression line, and in the other subsets the intercept of
the regression line, was significantly lower. Only the subset
of balanced translocations demonstrated TCD values within
the normal range of the TCD reference chart.
In fetuses with trisomy 18, only 9/14 fetuses (64%) with a
reduced HC (< 5th centile) and only 10/16 fetuses (63%)
with a reduced AC (< 5th centile) demonstrated a reduced
TCD. In fetuses with trisomy 21, these percentages were 43%
(3/7) and 20% (2/5), respectively.
The subsets of trisomies 18 and 21 were large enough to
compare the distribution of TCD values between the gesta-
tional age periods of before and after 25 weeks. No statisti-
cally significant difference was found. TCD values in trisomy
18 were significantly smaller than in trisomy 21.
The majority of structural abnormalities involved the central
nervous system, cardiovascular system, gastro-intestinal tract,
abdominal wall, renal tract and limbs. Fetal hydrops occurred
in the subsets of trisomy 21, sex chromosomal abnormalities
and unbalanced translocations. The majority of central nervous
system abnormalities was associated with trisomies 18 and
21, with emphasis on ventriculomegaly (n = 9) and choroid
plexus cysts (n = 10). No relationship existed between the
TCD distribution and the presence of central nervous system
abnormalities. The percentage of single abnormalities varied
between 8% in mosaicism and 33% in balanced translocations.
The percentage of multiple abnormalities ranged between
0% in balanced translocations and 88% in trisomy 18.
DISCUSSION
According to the International Society of Ultrasound in
Obstetrics and Gynecology, measurement of the fetal TCD
is part of the proposed minimum requirements for basic
ultrasound training in obstetrics and gynecology during the
second and third trimesters of pregnancy15. A number of
sonographic and morphologic reports have appeared on fetal
cerebellar size and chromosomal abnormalities, mainly in
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association with trisomies 18 and 21, and studied predomin-
antly during the early second trimester of pregnancy1–4.
In the present study fetal transcerebellar size was related to
a wide range of fetal numerical and structural chromosomal
abnormalities established during the second half of preg-
nancy. The results presented originate from a selected patient
cohort with the majority (62/88 = 70%) depicting either iso-
lated or multiple fetal congenital defects. Trisomy 18 and
trisomy 21 constituted nearly half (40/88 = 45.5%) of the
chromosomal abnormalities, the remaining representing a
mixture of ‘other numerical chromosomal abnormalities’, sex
chromosomal abnormalities, mosaicism and balanced and
unbalanced translocations.
Only in the subset of balanced translocations did the dis-
tribution of TCD measurements indicate normal cerebellar
size. In all other subsets a reduction in TCD was established
Figure 1 Individual data plots of transcerebellar diameter (TCD/mm) 
relative to gestational age (GA/weeks) (a), abdominal circumference 
(AC/mm) (b) and head circumference (HC/mm) (c) in trisomy 18 () 
and trisomy 21 (). Reference ranges represent 50th, 5th and 95th 
centiles14.
Figure 2 Individual data plots of transcerebellar diameter (TCD/mm) 
relative to gestational age (GA/weeks) (a), abdominal circumference 
(AC/mm) (b) and head circumference (HC/mm) (c) in ‘other numerical 
chromosomal abnormalities’ (), sex chromosomal abnormalities (), 
mosaicism ( ), balanced translocations () and unbalanced 
translocations (). Reference ranges represent 50th, 5th and 95th centiles14.
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reflecting some degree of cerebellar hypoplasia. Nevertheless,
TCD measurements cannot be used as a marker for chromo-
somal abnormalities since the majority of fetuses with chromo-
somal abnormalities displayed a TCD within the normal
range (5th–95th centile). Transcerebellar diameter is signi-
ficantly smaller in trisomy 18 compared with trisomy 21,
which indicates a difference in the degree of cerebellar
hypoplasia between the two subsets. Our finding of a reduced
fetal TCD in trisomies 18 and 21 corroborates previous
reports on cerebellar size1,4 and demonstrates that cerebellar
hypoplasia is developmentally established in the presence of
these chromosomal abnormalities. Our results are also com-
patible with tomographic and magnetic resonance studies9,10
which demonstrated cerebellar hypoplasia in infants with
Down syndrome. Computed tomography and ultrasono-
graphy also revealed cerebellar hypoplasia in neonates with
trisomy 13 and trisomy 185.
Cerebellar and overall head size may not only be affected
by an inherent inhibition of brain growth but also by a gen-
eralized disturbance of overall growth associated with chro-
mosomal abnormalities11,12. Although the numbers are small,
it is clear from Figures 1 and 2 that, whereas TCD is reduced
when related to gestational age, this is not so when related to
head or abdominal circumference. The observation in the
growth-restricted fetus that the TCD is not in every case situated
below the normal range is in agreement with a previous study
from our own center in which it was demonstrated that even in
severe growth restriction the TCD may only be mildly affected14.
It has been postulated that fetal development is character-
ized by two major periods of cellular multiplication in the
human brain, the first phase taking place at 15–20 weeks
of gestation and representing proliferation of neuroblasts,
the second phase starting at 25 weeks and proceeding until
2–4 years of age and merely concerned with glial division
and neuroblast maturation13. This may explain the absence
of a reduced TCD in Down syndrome fetuses at as early as
11–16 weeks of gestation3. Nonetheless, on comparison of
our data on TCDs before and after 25 weeks of gestation for
trisomies 18 and 21, no significant difference was established.
This suggests that in the second half of pregnancy, at least for
trisomies 18 and 21, the diagnosis of cerebellar hypoplasia is
independent of the time period during which the TCD meas-
urement is performed.
The few reports on cerebellar size relative to chromosomal
abnormalities other than trisomy 18 and trisomy 21 are all
based on studies in neonates and infants which describe CNS
malformations in association with chromosomal abnormal-
ities using either neuropathologic findings, or magnetic reson-
ance imaging or computed tomography5–8. According to
our results there seems to be no relationship between the pres-
ence of intracerebral pathology such as ventriculomegaly or
choroid plexus cysts and cerebellar size in either trisomy 18,
trisomy 21 or the other chromosomal abnormalities.
It can be concluded that during fetal life, a wide range of
chromosomal abnormalities is associated with a gestational
age-related reduction in TCD. Only in the presence of a
balanced translocation, was no such reduction demonstrated.
A significant difference in the degree of gestational age-related
reduction in fetal TCD between trisomy 18 and trisomy 21
was demonstrated. In both these subsets the established reduc-
tion in fetal cerebellar size in the second half of pregnancy is
independent of the time period during which the transcerebellar
diameter is measured.
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